share_log

DEFA14A: Others

DEFA14A: Others

DEFA14A:其他
美股SEC公告 ·  10/05 04:24

Moomoo AI 已提取核心訊息

Cardio Diagnostics Holdings, Inc. has filed definitive additional materials with the United States Securities and Exchange Commission (SEC) as part of its Schedule 14A Proxy Statement. This filing, pursuant to Section 14(a) of the Securities Exchange Act of 1934, indicates that the materials are intended for use in connection with a shareholder meeting or to solicit proxies. The company has confirmed that no filing fee is required for this submission. The definitive additional materials suggest that Cardio Diagnostics Holdings is preparing for upcoming corporate actions that require shareholder votes, although the specific resolutions or proposals are not detailed in this announcement.
Cardio Diagnostics Holdings, Inc. has filed definitive additional materials with the United States Securities and Exchange Commission (SEC) as part of its Schedule 14A Proxy Statement. This filing, pursuant to Section 14(a) of the Securities Exchange Act of 1934, indicates that the materials are intended for use in connection with a shareholder meeting or to solicit proxies. The company has confirmed that no filing fee is required for this submission. The definitive additional materials suggest that Cardio Diagnostics Holdings is preparing for upcoming corporate actions that require shareholder votes, although the specific resolutions or proposals are not detailed in this announcement.
Cardio Diagnostics Holdings公司已向美國證券交易委員會(SEC)提交了明確的附加材料,作爲其第14A表決權代理聲明的一部分。根據1934年證券交易法第14(a)條的規定,此次提交表明這些材料旨在與股東會議或請求代理投票有關。公司已確認此次提交無需提交任何文件費。明確的附加材料表明Cardio Diagnostics Holdings正在準備即將舉行的需要股東投票的公司行動,儘管此公告未詳細說明具體決議或提案。
Cardio Diagnostics Holdings公司已向美國證券交易委員會(SEC)提交了明確的附加材料,作爲其第14A表決權代理聲明的一部分。根據1934年證券交易法第14(a)條的規定,此次提交表明這些材料旨在與股東會議或請求代理投票有關。公司已確認此次提交無需提交任何文件費。明確的附加材料表明Cardio Diagnostics Holdings正在準備即將舉行的需要股東投票的公司行動,儘管此公告未詳細說明具體決議或提案。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息